PF4 and systemic sclerosis: It has been demonstrated that SSc patients have a significantly higher concentration of heparin-dependent anti-CXCL4 antibodies as compared to healthy donors; in particular, antibodies to CXCL4 can be either heparin-dependent or heparin-independent in SSc [67].